Aesculus Bio ApS: Financial statements 2025
CVR: 40560866
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Aesculus Bio ApS (CVR 40560866) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -154,862 and a net result of DKK -129,437 compared with DKK -45,866 the year before. Equity in the 2025 report amounted to DKK -34,097.
- Gross Profit
- DKK -154,862
- Profit/Loss
- DKK -129,437
- Equity
- DKK -34,097
- Total Assets
- DKK 308,997
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -155 t. | -129 t. | -34 t. | - |
| 2024 | - | -50 t. | -46 t. | 95 t. | - |
| 2023 | - | -14 t. | -11 t. | 141 t. | - |
| 2022 | - | -25 t. | -15 t. | 152 t. | - |
| 2021 | - | 88 t. | 74 t. | 167 t. | - |
Official annual report
How creditworthy is Aesculus Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Aesculus Bio ApS has published its annual report for 2024. Gross profit came to DKK -49,785, and the net result was DKK -45,866.
About Aesculus Bio ApS
Aesculus Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Benjamin Anderschou Holbech Jensen. The board consists of Peter Hviid Nordkild (chair) and Benjamin Anderschou Holbech Jensen. The company is owned by Benjamin Anderschou Holbech Jensen, PN INVESTMENT ApS and Jan Wehkamp. In 2025, the company reported a gross profit of DKK -154,862 and a net result of DKK -129,437 compared with DKK -45,866 the year before. Equity in the 2025 report amounted to DKK -34,097.